These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 38842109)
1. Ozone enhances the efficacy of radiation therapy in esophageal cancer. Guo J; Guo J; Cheng B; Gong M; Sun X; Zhang H; Ma J J Radiat Res; 2024 Jul; 65(4):467-473. PubMed ID: 38842109 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of ozone alleviation of malignant ascites in hepatocellular carcinoma through the inhibition of neutrophil extracellular traps. Han F; Guo J; Mu M; Bian K; Cui Z; Duan Q; Ma J; Jin L; Liu W; Chen F PNAS Nexus; 2023 Sep; 2(9):pgad280. PubMed ID: 37693209 [TBL] [Abstract][Full Text] [Related]
3. STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma. Zhang Q; Zhang C; He J; Guo Q; Hu D; Yang X; Wang J; Kang Y; She R; Wang Z; Li D; Huang G; Ma Z; Mao W; Zhou X; Xiao C; Sun X; Ma J Tumour Biol; 2015 Mar; 36(3):2135-42. PubMed ID: 25492480 [TBL] [Abstract][Full Text] [Related]
4. Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1α in vitro and in vivo. Yang X; Yang B; Cai J; Zhang C; Zhang Q; Xu L; Qin Q; Zhu H; Ma J; Tao G; Cheng H; Sun X Cancer Biol Ther; 2013 Nov; 14(11):1068-73. PubMed ID: 24025355 [TBL] [Abstract][Full Text] [Related]
5. Fenofibrate enhances radiosensitivity of esophageal squamous cell carcinoma by suppressing hypoxia-inducible factor-1α expression. Ge Y; Liu J; Yang X; Zhu H; Yang B; Zhao K; Wu Z; Cheng G; Wang F; Ni F; Ge Q; Yang Y; Tai G; Sun X; Cai J Tumour Biol; 2014 Nov; 35(11):10765-71. PubMed ID: 25073512 [TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin Increases the Sensitivity of Photodynamic Therapy Via NF-κB/HIF-1α/VEGF Pathway in Esophageal Cancer Cell in vitro and in vivo. Li Y; Sui H; Jiang C; Li S; Han Y; Huang P; Du X; Du J; Bai Y Cell Physiol Biochem; 2018; 48(5):2035-2045. PubMed ID: 30099443 [TBL] [Abstract][Full Text] [Related]
7. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells. Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487 [TBL] [Abstract][Full Text] [Related]
8. Vitexin enhances radiosensitivity of mouse subcutaneous xenograft glioma by affecting the miR-17-5p/miR-130b-3p/PTEN/HIF-1α pathway. Xie T; Ding YH; Sang CS; Lin ZX; Dong J; Fu XA Strahlenther Onkol; 2024 Jun; 200(6):535-543. PubMed ID: 38453699 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic target of rapamycin small interfering RNA and rapamycin synergistically inhibit tumour growth in a mouse xenograft model of human oesophageal carcinoma. Sun MM; Zhang MZ; Chen Y; Li SL; Zhang W; Ya GW; Chen KS J Int Med Res; 2012; 40(5):1636-43. PubMed ID: 23206445 [TBL] [Abstract][Full Text] [Related]
10. Vitexin, an inhibitor of hypoxia-inducible factor-1α, enhances the radiotherapy sensitization of hyperbaric oxygen on glioma. Xie T; Wang JR; Dai CG; Fu XA; Dong J; Huang Q Clin Transl Oncol; 2020 Jul; 22(7):1086-1093. PubMed ID: 31677055 [TBL] [Abstract][Full Text] [Related]
11. LKB1 promotes radioresistance in esophageal cancer cells exposed to radiation, by suppression of apoptosis and activation of autophagy via the AMPK pathway. He Q; Li J; Dong F; Cai C; Zou X Mol Med Rep; 2017 Aug; 16(2):2205-2210. PubMed ID: 28656285 [TBL] [Abstract][Full Text] [Related]
12. STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1α. Zhang C; Yang X; Zhang Q; Guo Q; He J; Qin Q; Zhu H; Liu J; Zhan L; Lu J; Liu Z; Xu L; Ma J; Dai S; Cheng H; Sun X Tumour Biol; 2014 Oct; 35(10):9793-9. PubMed ID: 24981247 [TBL] [Abstract][Full Text] [Related]
13. Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer. Schwartz DL; Bankson JA; Lemos R; Lai SY; Thittai AK; He Y; Hostetter G; Demeure MJ; Von Hoff DD; Powis G Mol Cancer Ther; 2010 Jul; 9(7):2057-67. PubMed ID: 20587661 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of hypoxia inducible factor 1α expression suppresses the progression of esophageal squamous cell carcinoma. Zhu H; Feng Y; Zhang J; Zhou X; Hao B; Zhang G; Shi R Cancer Biol Ther; 2011 Jun; 11(11):981-7. PubMed ID: 21519196 [TBL] [Abstract][Full Text] [Related]
15. HIF-1α contributes to hypoxia-induced invasion and metastasis of esophageal carcinoma via inhibiting E-cadherin and promoting MMP-2 expression. Jing SW; Wang YD; Kuroda M; Su JW; Sun GG; Liu Q; Cheng YJ; Yang CR Acta Med Okayama; 2012; 66(5):399-407. PubMed ID: 23093058 [TBL] [Abstract][Full Text] [Related]
16. Prediction of radiotherapy effect by diffusion-weighted imaging in esophageal carcinoma xenograft model. Zhang A; Su X; Wang Y; Shi GF; Han C; Zhang J; Wang L; Zhang R J Cancer Res Ther; 2020; 16(2):343-349. PubMed ID: 32474522 [TBL] [Abstract][Full Text] [Related]
17. Curcumin Administered in Combination with Glu-GNPs Induces Radiosensitivity in Transplanted Tumor MDA-MB-231-luc Cells in Nude Mice. Li M; Lin L; Guo T; Wu Y; Lin J; Liu Y; Yang K; Hu C Biomed Res Int; 2021; 2021():9262453. PubMed ID: 34825004 [TBL] [Abstract][Full Text] [Related]
18. 2-Methoxyestradiol promotes radiosensitivity of esophageal squamous cell carcinoma by suppressing hypoxia-inducible factor-1α expression. Lu YR; Song J; Zhabihula BX; Zhang JR Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10785-10795. PubMed ID: 31858546 [TBL] [Abstract][Full Text] [Related]
19. EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma. Lu J; Tang M; Li H; Xu Z; Weng X; Li J; Yu X; Zhao L; Liu H; Hu Y; Tan Z; Yang L; Zhong M; Zhou J; Fan J; Bode AM; Yi W; Gao J; Sun L; Cao Y Cancer Lett; 2016 Sep; 380(1):191-200. PubMed ID: 27255972 [TBL] [Abstract][Full Text] [Related]
20. The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo. Fujihara S; Morishita A; Ogawa K; Tadokoro T; Chiyo T; Kato K; Kobara H; Mori H; Iwama H; Masaki T Oncotarget; 2017 Jan; 8(5):8536-8549. PubMed ID: 28052030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]